Open Access

[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain

  • Authors:
    • Qingfu Deng
    • Li Luo
    • Zhen Quan
    • Nanjing Liu
    • Zhongbo Du
    • Wei Sun
    • Chunli Luo
    • Xiaohou Wu
  • View Affiliations

  • Published online on: May 23, 2022     https://doi.org/10.3892/mmr.2022.12746
  • Article Number: 230
  • Copyright : © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Mol Med Rep 19: [Related article:] 2115–2124, 2019; DOI: 10.3892/mmr.2019.9841

Following the publication of the above article, an interested reader drew to the authors’ attention that the western blotting data shown in Figs. 2F and 5E were strikingly similar, even though they were intended to show the results from differently performed experiments; furthermore, the migration assay images shown for the 24 h ‘Blank’ and ‘Vector’ experiments in Fig. 3C were apparently the same.

The authors have consulted their original data, and realized that the errors in the presentation of these figures arose inadvertently as a consequence of selecting the wrong images for the 24 h ‘Blank’ experiement in Fig. 3C and the western blot for the AR / Nucleus experiment in Fig. 5E. The revised versions of Figs. 3 and 5 are shown on the next two pages. All the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret that these errors were included in the paper, and also apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

July-2022
Volume 26 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Deng Q, Luo L, Quan Z, Liu N, Du Z, Sun W, Luo C and Wu X: [Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain. Mol Med Rep 26: 230, 2022
APA
Deng, Q., Luo, L., Quan, Z., Liu, N., Du, Z., Sun, W. ... Wu, X. (2022). [Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain. Molecular Medicine Reports, 26, 230. https://doi.org/10.3892/mmr.2022.12746
MLA
Deng, Q., Luo, L., Quan, Z., Liu, N., Du, Z., Sun, W., Luo, C., Wu, X."[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain". Molecular Medicine Reports 26.1 (2022): 230.
Chicago
Deng, Q., Luo, L., Quan, Z., Liu, N., Du, Z., Sun, W., Luo, C., Wu, X."[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain". Molecular Medicine Reports 26, no. 1 (2022): 230. https://doi.org/10.3892/mmr.2022.12746